IMPAX LABS FDA Approval ANDA 084927

ANDA 084927

IMPAX LABS

FDA Drug Application

Application #084927

Application Sponsors

ANDA 084927IMPAX LABS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL500MG0METHOCARBAMOLMETHOCARBAMOL

FDA Submissions

ORIG1AP1976-08-20
MANUF (CMC); Manufacturing (CMC)SUPPL22AP1983-12-20
MANUF (CMC); Manufacturing (CMC)SUPPL23AP1983-12-20
MANUF (CMC); Manufacturing (CMC)SUPPL24AP1986-08-15
MANUF (CMC); Manufacturing (CMC)SUPPL25AP1986-08-15
MANUF (CMC); Manufacturing (CMC)SUPPL26AP1987-07-02
MANUF (CMC); Manufacturing (CMC)SUPPL27AP1988-04-15
MANUF (CMC); Manufacturing (CMC)SUPPL28AP1987-09-03
MANUF (CMC); Manufacturing (CMC)SUPPL29AP1987-11-10
LABELING; LabelingSUPPL30AP1988-12-22
LABELING; LabelingSUPPL31AP1989-01-25

Submissions Property Types

SUPPL22Null0
SUPPL23Null0
SUPPL24Null0
SUPPL25Null0
SUPPL26Null0
SUPPL27Null0
SUPPL28Null0
SUPPL29Null0

CDER Filings

IMPAX LABS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 84927
            [companyName] => IMPAX LABS
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHOCARBAMOL","activeIngredients":"METHOCARBAMOL","strength":"500MG","dosageForm":"TABLET;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"METHOCARBAMOL","submission":"METHOCARBAMOL","actionType":"500MG","submissionClassification":"TABLET;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.